J Russell Geyer

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group
    J Russell Geyer
    Children s Hospital and Regional Medical Center, Department of Pediatric Hematology Oncology, Seattle, WA 98105, USA
    J Clin Oncol 23:7621-31. 2005
  2. ncbi request reprint Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors
    Michael S Bobola
    Division of Neurosurgery, Department of Surgery, Children s Hospital and Regional Medical Center, Seattle, WA 98105, USA
    Clin Cancer Res 11:7405-14. 2005
  3. doi request reprint Gross total resection correlates with long-term survival in pediatric patients with glioblastoma
    Tong Yang
    Department of Neurosurgery, School of Public Health, University of Washington School of Medicine, Seattle Children s Hospital, Seattle, Washington, USA
    World Neurosurg 79:537-44. 2013
  4. ncbi request reprint Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas
    James G Douglas
    Department of Radiation Oncology, University of Washington, Seattle, 98195, USA
    J Pediatr Hematol Oncol 28:36-9. 2006
  5. ncbi request reprint Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse
    Blythe Thomson
    Seattle Children s Hospital and Regional Medical Center, Seattle, Washington, USA
    Pediatr Blood Cancer 43:571-9. 2004
  6. ncbi request reprint DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma
    Carlo Giussani
    Department of Neurological Surgery, University of Washington School of Medicine, Seattle Children s Hospital, Seattle, WA 98105, USA
    Neuroimage 52:217-23. 2010
  7. pmc A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
    J Russell Geyer
    Seattle Children s Hospital, Seattle, WA, USA
    Eur J Cancer 46:3287-93. 2010
  8. doi request reprint Diffusion tensor imaging of the superior cerebellar peduncle identifies patients with posterior fossa syndrome
    Jeffrey G Ojemann
    Neurosurgery, Seattle Children s Hospital, Seattle, WA, USA
    Childs Nerv Syst 29:2071-7. 2013
  9. doi request reprint MRI changes associated with vigabatrin treatment mimicking tumor progression
    Tong Yang
    Department of Neurological Surgery, University of Washington School of Medicine, Seattle Children s Hospital, Seattle, Washington, USA
    Pediatr Blood Cancer 55:1221-3. 2010
  10. ncbi request reprint Adrenocorticotropin-secreting pancreatoblastoma
    Gad B Kletter
    Pediatric Endocrine, Swedish Physician Division 1101 Madison, Suite 800, Seattle, WA 98104, USA
    J Pediatr Endocrinol Metab 20:639-42. 2007

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group
    J Russell Geyer
    Children s Hospital and Regional Medical Center, Department of Pediatric Hematology Oncology, Seattle, WA 98105, USA
    J Clin Oncol 23:7621-31. 2005
    ....
  2. ncbi request reprint Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors
    Michael S Bobola
    Division of Neurosurgery, Department of Surgery, Children s Hospital and Regional Medical Center, Seattle, WA 98105, USA
    Clin Cancer Res 11:7405-14. 2005
    ....
  3. doi request reprint Gross total resection correlates with long-term survival in pediatric patients with glioblastoma
    Tong Yang
    Department of Neurosurgery, School of Public Health, University of Washington School of Medicine, Seattle Children s Hospital, Seattle, Washington, USA
    World Neurosurg 79:537-44. 2013
    ..We set out to study patients younger than 18 years of age, carrying the diagnosis of glioblastoma not of the brainstem, their clinical characteristics and clinical factors associated with clinical outcome...
  4. ncbi request reprint Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas
    James G Douglas
    Department of Radiation Oncology, University of Washington, Seattle, 98195, USA
    J Pediatr Hematol Oncol 28:36-9. 2006
    ..6-36 Gy) retains the excellent survival rates for patients with localized, pure germinomas of the CNS. A higher rate of ventricular relapse rate is observed, although salvage of those patients is feasible...
  5. ncbi request reprint Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse
    Blythe Thomson
    Seattle Children s Hospital and Regional Medical Center, Seattle, Washington, USA
    Pediatr Blood Cancer 43:571-9. 2004
    ..The ability to achieve a durable second remission is complicated by toxicity and resistant disease. We report a novel combination of chemotherapy for relapsed pediatric ALL...
  6. ncbi request reprint DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma
    Carlo Giussani
    Department of Neurological Surgery, University of Washington School of Medicine, Seattle Children s Hospital, Seattle, WA 98105, USA
    Neuroimage 52:217-23. 2010
    ....
  7. pmc A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
    J Russell Geyer
    Seattle Children s Hospital, Seattle, WA, USA
    Eur J Cancer 46:3287-93. 2010
    ....
  8. doi request reprint Diffusion tensor imaging of the superior cerebellar peduncle identifies patients with posterior fossa syndrome
    Jeffrey G Ojemann
    Neurosurgery, Seattle Children s Hospital, Seattle, WA, USA
    Childs Nerv Syst 29:2071-7. 2013
    ..Using diffusion tensor imaging (DTI), we examined the involvement of the dentothalamic tracts, specifically the superior cerebellar peduncle (SCP), in patients with posterior fossa tumors and the association with PFS...
  9. doi request reprint MRI changes associated with vigabatrin treatment mimicking tumor progression
    Tong Yang
    Department of Neurological Surgery, University of Washington School of Medicine, Seattle Children s Hospital, Seattle, Washington, USA
    Pediatr Blood Cancer 55:1221-3. 2010
    ..This report highlights the fact that vigabatrin treatment can mimic tumor progression on MRI and confound management of tumors associated with seizures in pediatric patients...
  10. ncbi request reprint Adrenocorticotropin-secreting pancreatoblastoma
    Gad B Kletter
    Pediatric Endocrine, Swedish Physician Division 1101 Madison, Suite 800, Seattle, WA 98104, USA
    J Pediatr Endocrinol Metab 20:639-42. 2007
    ..This malignancy is a rare cause of Cushing's syndrome, particularly at pediatric age. We describe her course including the use of ketoconazole to alleviate hypercortisolemia...
  11. ncbi request reprint Spinal cord pilocytic astrocytoma with leptomeningeal dissemination to the brain. Case report and review of the literature
    Taylor J Abel
    Department of Neurological Surgery, Division of Hematology Oncology, Children s Hospital and Regional Medical Center, University of Washington School of Medicine, Seattle, Washington 98105, USA
    J Neurosurg 105:508-14. 2006
    ..This case illustrates a unique instance of supratentorial leptomeningeal dissemination of an intramedullary spinal cord PCA in a child...
  12. ncbi request reprint O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines
    Michael S Bobola
    Division of Neurosurgery, Department of Surgery and Hematology Oncology, Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    Clin Cancer Res 11:2747-55. 2005
    ..Few such data for pediatric glioma lines, particularly those from low-grade tumors, are currently available...
  13. ncbi request reprint Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure
    James G Douglas
    Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA 98195, USA
    Int J Radiat Oncol Biol Phys 58:1161-4. 2004
    ..To review the efficacy and patterns of failure in average-risk medulloblastoma patients treated with concurrent chemotherapy and reduced-dose cranial spinal irradiation and a conformal tumor bed boost...
  14. pmc Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report
    Ian F Pollack
    Department of Neurosurgery, Children s Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA
    Neuro Oncol 9:145-60. 2007
    ..Imatinib may increase the risk of ITH, although the incidence of spontaneous hemorrhages in brainstem glioma is sufficiently high that this should be considered in studies of agents in which hemorrhage is a concern...
  15. ncbi request reprint Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Cons
    Mark W Kieran
    Dana Farber Cancer Institute and Children s Hospital Boston, Boston, MA 02115, USA
    J Clin Oncol 25:3137-43. 2007
    ..Primary objectives were to estimate the maximum-tolerated dose (MTD) and to describe the dose-limiting toxicities (DLTs) and pharmacokinetics of lonafarnib. Farnesylation inhibition of HDJ-2 in peripheral blood was also measured...
  16. ncbi request reprint Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients
    Burgess B Freeman
    Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, Tennessee, USA
    Cancer Invest 24:310-7. 2006
    ..Finally, the future for the use of gefitinib in pediatrics is similar to that of other molecularly targeted agents and awaits definition of tumors and patient populations in which it will be most advantageous...
  17. pmc Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma
    Daphne A Haas-Kogan
    University of California, San Francisco, San Francisco, CA, USA
    Neuro Oncol 10:341-7. 2008
    ..The MTD of tipifarnib with concurrent radiation is 125 mg/m(2)/dose b.i.d. One-year survival and progression-free survival estimates are 36.4% (SE 16.7%) and 9.4% (SE 6.3%), respectively...
  18. ncbi request reprint Intrathecal mafosfamide: a preclinical pharmacology and phase I trial
    Susan M Blaney
    Texas Children s Cancer Center, 6621 Fannin St, CC 1410 00, Houston, TX 77030 2399, USA
    J Clin Oncol 23:1555-63. 2005
    ..A phase I and pharmacokinetic study of IT mafosfamide was performed to determine a dose for subsequent phase II trials...
  19. pmc A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952
    Seema N Sanghavi
    Department of Human Oncology, Medical School, University of Wisconsin, 600 Highland Avenue, Madison, WI 53792, USA
    Neuro Oncol 5:8-13. 2003
    ..50 mg/m(2) x 33 (total dosage = 16.5 mg/m(2)); the recommended safe MTD of daily topotecan for further phase II testing is 0.40 mg/m(2) x 33 (total dosage = 13.2 mg/m(2))...
  20. ncbi request reprint Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop
    Roger J Packer
    Department of Neurology, Children s National Medical Center, The George Washington University Medical Center, Washington, DC 20010, USA
    J Pediatr Hematol Oncol 24:337-42. 2002
    ..Therapeutic approached have included surgery, chemotherapy, and radiotherapy. Prospective clinical trials are needed for children with AT/RTs...